-inc-logo-1200x675.png){kind=logo}
Mind Medicine (MindMed) Inc. (OTCMKTS:MMEDF – Get Free Report) fell 1.7% during mid-day trading on Thursday . The company traded as low as $5.92 and last traded at $5.96. 588,821 shares were traded during mid-day trading, a decline of 83% from the average session volume of 3,376,665 shares. The stock had previously closed at $6.06.
Mind Medicine (MindMed) Trading Down 1.7 %
The firm’s fifty day moving average is $6.93 and its 200 day moving average is $8.06.
About Mind Medicine (MindMed)
Mind Medicine (MindMed) Inc, a psychedelic medicine biotech company, discovers, develops, and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. The company is assembling a compelling drug development pipeline of innovative treatments based on psychedelic substances, including Psilocybin, LSD, MDMA, DMT, and an Ibogaine derivative, 18-MC.
See Also
- Five stocks we like better than Mind Medicine (MindMed)
- Russell 2000 Index, How Investors Use it For Profitable Trading
- Rocket Lab Stock Soars: Should Investors Chase the Rally?
- Utilities Stocks Explained – How and Why to Invest in Utilities
- KB Home Slips After Earnings: What’s Next for Homebuilders?
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- Micron Stock Soars as AI Demand Fuels Big Q4 Earnings Beat
Receive News & Ratings for Mind Medicine (MindMed) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mind Medicine (MindMed) and related companies with MarketBeat.com's FREE daily email newsletter.
